Cloning of the 5' regulatory regions and functional characterization of the core promoters of ovine PLAU (u-PA) and SERPIN1 (PAI-1)

Gene

Volumn 489, Issue 1, 2011, Pages 11-20

  Lampidonis, A D ^a   Theodorou, G ^a,b   Pecorini, C ^b   Rebucci, R ^b   Baldi, A ^b   Politis, I ^a  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bovine mammary epithelium; Ovis aries; Plasminogen activator inhibitor 1 (PAI 1); Transcriptional regulation; Urokinase plasminogen activator (u PA)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TRANSCRIPTION FACTOR; UROKINASE;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST EPITHELIUM; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOMIC FRAGMENT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; SHEEP; TATA BOX; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION;

ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE; CLONING, MOLECULAR; FEMALE; MAMMARY GLANDS, ANIMAL; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; SHEEP; TATA BOX; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION INITIATION SITE; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

BOVINAE; OVIS; OVIS ARIES;

EID: 80053979208     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.08.020     Document Type: Article

References (52)

1. Aguirre Ghiso J.A., Alonso D.F., Farias E.F., Bal de Kier J.E. Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells. Biochim. Biophys. Acta 1997, 1356:171-184.
2. Ahn J.D., et al. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia 2001, 44:713-720.
3. Alfano D., et al. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb. Haemost. 2005, 93:205-211.
4. Alroy I., Soussan L., Seger R., Yarden Y. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol. Cell. Biol. 1999, 19:1961-1972.
5. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
6. Benasciutti E., Pages G., Kenzior O., Folk W., Blasi F., Crippa M.P. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 2004, 104:256-262.
7. Bosma P.J., van den Berg E.A., Kooistra T., Siemieniak D.R., Slightom J.L. Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J. Biol. Chem. 1988, 263:9129-9141.
8. Briggs M.R., Kadonaga J.T., Bell S.P., Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 1986, 234:47-52.
9. Bruch M., Weiss V., Engel J. Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J. Biol. Chem. 1988, 263:16630.
10. Bruzdzinski C.J., Riordan-Johnson M., Nordby E.C., Suter S.M., Gelehrter T.D. Isolation and characterization of the rat plasminogen activator inhibitor-1 gene. J. Biol. Chem. 1990, 265:2078-2085.
11. Busso N., Belin D., Failly-Crepin C., Vassalli J.D. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Cancer Res. 1987, 47:364-370.
12. Chen Q.K., Hertz G.Z., Stormo G.D. PromFD 1.0: a computer program that predicts eukaryotic pol II promoters using strings and IMD matrices. Comput. Appl. Biosci. 1997, 13:29-35.
13. Chen Y.Q., Su M., Walia R.R., Hao Q., Covington J.W., Vaughan D.E. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J. Biol. Chem. 1998, 273:8225-8231.
14. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 1988, 16:10881-10890.
15. Degen S.J., Heckel J.L., Reich E., Degen J.L. The murine urokinase-type plasminogen activator gene. Biochemistry (Mosc) 1987, 26:8270-8279.
16. Don R.H., Cox P.T., Wainwright B.J., Baker K., Mattick J.S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 1991, 19:4008.
17. Dunn S.E., Torres J.V., Nihei N., Barrett J.C. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy. Mol. Carcinog. 2000, 27:10-17.
18. Fay W.P., Garg N., Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1231-1237.
19. Frith M.C., Hansen U., Weng Z. Detection of cis-element clusters in higher eukaryotic DNA. Bioinformatics 2001, 17:878-889.
20. Goldberg H.J., Scholey J., Fantus I.G. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 2000, 49:863-871.
21. Heinemeyer T., et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 1998, 26:362-367.
22. Ibanez-Tallon I., Ferrai C., Longobardi E., Facetti I., Blasi F., Crippa M.P. Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. Blood 2002, 100:3325-3332.
23. Irigoyen J.P., Besser D., Nagamine Y. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway. J. Biol. Chem. 1997, 272:1904-1909.
24. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 1994, 14:116-127.
25. Keeton M.R., Curriden S.A., van Zonneveld A.J., Loskutoff D.J. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem. 1991, 266:23048-23052.
26. Leslie N.D., Kessler C.A., Bell S.M., Degen J.L. The chicken urokinase-type plasminogen activator gene. J. Biol. Chem. 1990, 265:1339-1344.
27. Lijnen H.R. Pleiotropic functions of plasminogen activator inhibitor-1. J. Thromb. Haemost. 2005, 3:35-45.
28. Medcalf R.L., Kruithof E.K., Schleuning W.D. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J. Exp. Med. 1988, 168:751-759.
29. Mondino A., Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 2004, 25:450-455.
30. Munoz-Canoves P., Miralles F., Baiget M., Felez J. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro. Thromb. Haemost. 1997, 77:526-534.
31. Ogbourne S., Antalis T.M. Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes. Biochem. J. 1998, 331(Pt 1):1-14.
32. Politis I. Plasminogen activator system: implications for mammary cell growth and involution. J. Dairy Sci. 1996, 79:1097-1107.
33. Politis I., Zavizion B., White J.H., Goldberg J.J., Baldi A., Akers R.M. Hormonal and extracellular matrix regulation of plasminogen activator in a bovine mammary epithelial cell line. Endocrine 1995, 3:345-350.
34. Prendergast G.C., Diamond L.E., Dahl D., Cole M.D. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 1990, 10:1265-1269.
35. Prestridge D.S. Predicting Pol II promoter sequences using transcription factor binding sites. J. Mol. Biol. 1995, 249:923-932.
36. Rabot A., Sinowatz F., Berisha B., Meyer H.H., Schams D. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution. J. Dairy Sci. 2007, 90:740-748.
37. Riccio A., Grimaldi G., Verde P., Sebastio G., Boast S., Blasi F. The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res. 1985, 13:2759-2771.
38. Sasaki C.Y., Lin H., Passaniti A. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells. J. Cell. Physiol. 1999, 181:1-13.
39. Scherf M., Klingenhoff A., Werner T. Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. J. Mol. Biol. 2000, 297:599-606.
40. Sementchenko V.I., Watson D.K. Ets target genes: past, present and future. Oncogene 2000, 19:6533-6548.
41. Smale S.T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta 1997, 1351:73-88.
42. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell 1989, 57:103-113.
43. Sugiura T., et al. Increased HGF and c-Met in muscle tissues of polymyositis and dermatomyositis patients: beneficial roles of HGF in muscle regeneration. Clin. Immunol. 2010, 136:387-399.
44. Theodorou G., Bizelis I., Rogdakis E., Politis I. The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues. Gene 2009, 443:158-169.
45. Theodorou G., Bizelis I., Rogdakis E., Politis I. The ovine urokinase plasminogen activator inhibitors type 1 and 2 cDNAs: molecular cloning, characterization and expression in various tissues. Gene 2010, 454:20-30.
46. Tobar N., Villar V., Santibanez J.F. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol. Cell. Biochem. 2010, 340:195-202.
47. Toriseva M., Kahari V.M. Proteinases in cutaneous wound healing. Cell Mol. Life Sci. 2009, 66:203-224.
48. Tsai C.C., Saffitz J.E., Billadello J.J. Expression of the Gs protein alpha-subunit disrupts the normal program of differentiation in cultured murine myogenic cells. J. Clin. Invest 1997, 99:67-76.
49. Tsunoda T., Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics 1999, 15:622-630.
50. Watabe T., et al. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 1998, 77:128-137.
51. Watanabe M., et al. Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5. Invest Ophthalmol. Vis. Sci. 2006, 47:1862-1868.
52. Zavizion B., van Duffelen M., Schaeffer W., Politis I. Establishment and characterization of a bovine mammary epithelial cell line with unique properties. In vitro cell. Dev. Biol. Anim. 1996, 32:138-148.